Dr. Lauren Henke, MD
Claim this profileWashington University School of Medicine
Studies Cancer
Studies Lung Cancer
16 reported clinical trials
28 drugs studied
Area of expertise
1Cancer
Stage I
Stage II
Stage III
2Lung Cancer
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Lauren Henke, MD is currently running
HyperSight Imaging
for Pelvic Cancer
Cone beam computed tomography (CBCT) images are routinely used in radiation treatment delivery workflows to align patients with the treatment beam. Conventional CBCT image quality is sufficient for this task but not good enough for other radiotherapy-related tasks, such as contouring anatomical structures and calculating radiation dose distributions. HyperSight is a new CBCT imaging system manufactured by Varian Medical Systems. The purpose of this study is to evaluate the integration of the HyperSight imaging system with Varian's TrueBeam radiotherapy system, a linear accelerator with a C-arm gantry that rotates about the patient to delivery radiation to the target malignancy. HyperSight CBCT images will be acquired prospectively from patients who are receiving radiation treatment. The HyperSight/TrueBeam system will be used for imaging only; patients receive their radiation treatment on cleared devices and no aspect of their treatment is affected by participation in the study. HyperSight images collected during the study will be evaluated for quality and utility and compared to conventional CBCT images as well as fan beam CT images used for treatment planning.
Recruiting1 award N/A
Proton vs Photon Therapy
for Liver Cancer
This phase III trial studies how well radiation therapy with protons works compared with photons in treating patients with liver cancer. Radiation therapy, such as photon therapy, uses high energy x-rays to send the radiation inside the body to the tumor while proton therapy uses a beam of proton particles. Proton therapy can stop shortly after penetrating through the tumor and may cause less damage to the surrounding healthy organs and result in better survival in patients with liver cancer.
Recruiting2 awards Phase 3
More about Lauren Henke, MD
Clinical Trial Related2 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 10 Active Clinical TrialsTreatments Lauren Henke, MD has experience with
- Radiation Therapy
- Paclitaxel
- Intensity-Modulated Radiation Therapy
- Volumetric MR Imaging
- Halcyon 4.0 System
- HyperSight Imaging
Breakdown of trials Lauren Henke, MD has run
Cancer
Lung Cancer
Rectal Cancer
Colorectal Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lauren Henke, MD specialize in?
Lauren Henke, MD focuses on Cancer and Lung Cancer. In particular, much of their work with Cancer has involved Stage I patients, or patients who are Stage II.
Is Lauren Henke, MD currently recruiting for clinical trials?
Yes, Lauren Henke, MD is currently recruiting for 10 clinical trials in Saint Louis Missouri. If you're interested in participating, you should apply.
Are there any treatments that Lauren Henke, MD has studied deeply?
Yes, Lauren Henke, MD has studied treatments such as Radiation therapy, Paclitaxel, Intensity-Modulated Radiation Therapy.
What is the best way to schedule an appointment with Lauren Henke, MD?
Apply for one of the trials that Lauren Henke, MD is conducting.
What is the office address of Lauren Henke, MD?
The office of Lauren Henke, MD is located at: Washington University School of Medicine, Saint Louis, Missouri 63110 United States. This is the address for their practice at the Washington University School of Medicine.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.